Ernexa Therapeutics Inc.

NASDAQ: ERNA · Real-Time Price · USD
1.25
0.07 (5.93%)
At close: Sep 16, 2025, 3:59 PM
1.25
0.00%
After-hours: Sep 16, 2025, 04:10 PM EDT

Ernexa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-43.7M -46.09M -44.54M -44.93M -23.92M -22.9M -21.67M -20M -21.73M -20.62M -24.58M -28.55M -107.29M -113.98M -122.31M -116.06M -32.03M -23.97M
Depreciation & Amortization
643K 1.17M 1.64M 2.05M 2.12M 1.6M 1.12M 728K 332K 421K 497K 534.4K 536.81K 502.1K 459K 360.69K 262.55K 169.9K
Stock-Based Compensation
1.69M 1.74M 1.52M 1.27M 1.04M 835K 1.24M 1.47M 1.78M 2.44M 2.94M 4.47M 5.72M 6.25M 5.24M 3.32M 1.62M 237.26K
Other Working Capital
-3.23M -2.59M -2.15M 1.57M 1.48M -412K -571K -6.06M -1.07M 673K 300K 2.35M 287.21K -1.76M -2.46M -2.13M -2.44M -789.66K
Other Non-Cash Items
31.93M 31.76M 27.52M 24.64M 1.95M 2.01M 1.01M -355K -1.25M -5.67M -3.54M -1.88M 79.57M 83.15M 86.12M 85.55M 4.95M 5.2M
Deferred Income Tax
n/a n/a n/a 210K 190K n/a n/a -210K -190K n/a n/a 106.00 -297.17K -247.17K 9.35M 9.35M 9.65M 9.6M
Change in Working Capital
-4.99M -2.73M -1.97M -193K 2.13M 343K -2.12M -2.81M -408K 1.83M 3.71M 3.06M -919.73K -1.17M -2.35M -823.23K 1.27M -884.36K
Operating Cash Flow
-14.43M -14.15M -15.84M -16.95M -16.49M -18.11M -20.41M -21.18M -21.47M -21.59M -20.98M -22.37M -22.68M -25.49M -23.49M -18.3M -14.28M -9.66M
Capital Expenditures
-19K -268K -369K -388K -369K -120K -19K -21K -64K -251K -297K -423.14K -387K -200K -154K -19.68K -12.82K -34.54K
Cash Acquisitions
-4K -4K n/a n/a 4K 4K n/a 150K 150K 250K 250K 99.35K -22.75M -22.85M -22.71M -22.71M 147.26K 147.73K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
4K 4K 4K 4K n/a n/a n/a 150K 150K 150K 150K 406.00 406.00 406.00 119K 118.59K 118.59K 118.59K
Investing Cash Flow
-19K -268K -365K -384K -365K -116K -19K 129K 86K -1K -47K -323.39K -23.14M -23.05M -22.74M -22.61M 253.03K 231.78K
Debt Repayment
6.14M 6.14M 5.29M 13.08M 17.73M 17.73M 16.33M 8.54M -2K -2K -2K -411.01K -410.01K -410.01K -942K -531.9K -531.9K -221.99K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
8K n/a n/a -16K -16K -16K -16K -16K -16K -16K -16K -16K -16K -8K -8K n/a n/a n/a
Other Financial Acitivies
n/a -14K -34K -110K -110K -104K -84K -119K -112K -117K -117K -6.2K -13.2K 10.5M 10.5M 10.22M 10.5M n/a
Financial Cash Flow
12.08M 7.13M 6.26M 12.95M 17.61M 17.94M 16.56M 16.45M 7.91M 7.59M 19.58M 11.57M 15.06M 63.63M 61.59M 62.23M 59M 14.3M
Net Cash Flow
1.73M -3.2M -5.85M -287K 749K -281K -3.87M -4.61M -13.47M -14.01M -1.44M -11.13M -30.76M 15.09M 15.35M 21.33M 44.98M 4.87M
Free Cash Flow
-14.45M -14.42M -16.2M -17.34M -16.86M -18.23M -20.43M -21.2M -21.54M -21.84M -21.27M -22.79M -23.07M -25.69M -23.64M -18.32M -14.29M -9.69M